Lyell Immunopharma Inc. (LYEL)

AI Score

Unlock

0.46

-0.02 (-3.77%)

At close: Apr 24, 2025, 3:59 PM

0.47

0.95%

After-hours: Apr 24, 2025, 04:32 PM EDT

Lyell Immunopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	105.6M	100.3M	133.42M	125.65M	145.65M	286.21M	224.37M	109.43M	123.55M	116.31M	205.74M	222.6M	293.83M	393.5M	564.44M	244.37M	140.41M	-436.05M
Short-Term Investments	264.93M	340.25M	357.69M	400.65M	400.58M	289.22M	371.38M	503.34M	516.6M	531.82M	449.82M	391.32M	320.97M	225.42M	260.08M	360.56M	472.21M	872.1M
Long-Term Investments	32.01M	39.11M	19.29M	19.29M	48.51M	54.73M	68.95M	90.18M	115.04M	144.52M	178.44M	271.12M	330.53M	400.96M	233.71M	118.65M	163.44M	n/a
Other Long-Term Assets	6.31M	5.35M	4.24M	4.24M	4.52M	4.71M	4.8M	4.88M	4.96M	3.19M	3.99M	3.85M	3.95M	3.13M	3.26M	3.93M	3.23M	-436.05M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	9.07M	9.5M	8.71M	7.87M	8.46M	11.42M	10.66M	11.63M	11.14M	11.61M	11.21M	11.79M	11.49M	12.23M	10.32M	4.8M	n/a	n/a
Total Current Assets	379.59M	450.05M	499.82M	534.16M	554.69M	586.85M	606.41M	624.4M	651.29M	659.75M	666.78M	625.71M	626.29M	631.15M	834.84M	609.74M	617.55M	436.05M
Property-Plant & Equipment	72.94M	124.71M	130.79M	136.53M	142.32M	148.7M	155.19M	160.99M	166.26M	169.81M	172.47M	171.43M	166.64M	163.09M	158.06M	144.87M	124.06M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	111.27M	169.17M	154.32M	160.06M	195.34M	208.13M	228.94M	256.05M	286.27M	317.52M	354.9M	446.4M	501.12M	567.19M	395.03M	267.45M	290.73M	-436.05M
Total Assets	490.86M	619.22M	654.14M	694.22M	750.03M	794.99M	835.35M	880.45M	937.56M	977.27M	1.02B	1.07B	1.13B	1.2B	1.23B	877.19M	908.28M	n/a
Account Payables	5.37M	3.6M	4.2M	4.89M	4.82M	4.37M	5.8M	5.73M	3.92M	4.79M	4.25M	6.51M	3.21M	3.53M	4.86M	7.12M	9.4M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	20.36M	-6.06M	-5.85M	-4.81M	21.87M	11.19M	15.43M	6.22M	4.99M	5.58M	8.23M	7.92M	6.09M	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	22.72M	907K	1.01M	2.54M	8.79M	1.05M	3.75M	2.65M	13.13M	11.66M	9.22M	5.63M	20.08M	25.12M	25.01M	15.74M	21.28M	n/a
Total Current Liabilities	53.79M	33.51M	30.88M	32.35M	34.52M	35.06M	34.39M	30.8M	37.03M	51.22M	50.29M	41.05M	46.74M	59.28M	63.66M	56.81M	49.28M	n/a
Long-Term Debt	n/a	n/a	53.32M	55.16M	n/a	58.58M	60.22M	61.83M	63.17M	n/a	66.07M	67.47M	66.65M	65.68M	61.47M	n/a	n/a	n/a
Other Long-Term Liabilities	3.25M	3.56M	-49.88M	-51.61M	3.66M	-54.8M	-56.33M	-57.83M	-59.05M	4.23M	-61.73M	-63.02M	-62.08M	-60.67M	-60.57M	893K	89.6M	n/a
Total Long-Term Liabilities	54.25M	55.01M	56.76M	58.71M	60.56M	62.35M	64.11M	65.83M	67.28M	106.03M	103.34M	149.8M	150.88M	152.58M	144.25M	143.46M	140.56M	n/a
Total Liabilities	108.03M	88.52M	87.64M	91.06M	95.08M	97.42M	98.5M	96.62M	104.31M	157.24M	153.63M	190.85M	197.62M	211.86M	207.91M	200.27M	189.84M	n/a
Total Debt	58.97M	51.44M	60.22M	61.83M	63.17M	58.58M	60.22M	61.83M	67.7M	64.64M	66.07M	67.47M	67.82M	65.68M	61.47M	57.76M	54.57M	n/a
Common Stock	29K	26K	26K	25K	25K	25K	25K	25K	25K	25K	25K	25K	24K	24K	24K	2K	2K	n/a
Retained Earnings	-1.35B	-1.15B	-1.11B	-1.06B	-1B	-949.18M	-898.33M	-834.44M	-767.48M	-759.08M	-688.83M	-652.51M	-584.36M	-500.66M	-451.78M	-389.19M	-334.14M	n/a
Comprehensive Income	291K	760K	-397K	-404K	-94K	-1.18M	-2.38M	-3.88M	-7.6M	-10M	-8.35M	-6.6M	-1.62M	-65K	73K	163K	256K	-111.11M
Shareholders Equity	382.82M	530.7M	566.5M	603.16M	654.95M	697.57M	736.86M	783.83M	833.25M	820.03M	868.04M	881.25M	929.79M	986.47M	1.02B	676.92M	718.44M	408.06M
Total Investments	296.94M	379.36M	376.98M	419.94M	449.08M	321.22M	403.38M	538.27M	631.64M	676.34M	628.26M	662.43M	651.5M	626.38M	493.79M	479.21M	635.66M	872.1M